The BIO International Convention’s organizers counted more than 16,000 guests from 74 countries and 41,400 partnering meetings this year – a new record. The Austrian joint stand, which has been offering domestic companies a well-established and popular presentation platform, also saw a lot of heavy traffic. As in previous years, the joint stand used the Life Science Austria (LISA) flag in close cooperation with the international brand of the Austrian Federal Economic Chamber. LISAvienna assisted Viennese companies on site and used the event to discover current trends via the lecture programme. LISAvienna also raised awareness about Viennese companies and research institutions at the exhibition stand and in partnering meetings, and answered questions about Vienna as a prime place for international companies.
In addition to drug development, there was a lot of emphasis on the interface between the laboratory and IT as well as on diagnostics, especially in conjunction with personalized medicine. In order to successfully bring products to the market, a lot of problem-solving expertise is required to solve the details associated with execution. However, this does not necessarily mean that there is a need for visionaries that develop entirely new concepts for the future. Rather, there is a clear need for teams of experts that are able to develop marketable products from existing ideas. One significant aspect in this regard is familiarizing oneself with the mechanisms and networks of the global health economy and, based on this, develop tailor-made finance and marketing strategies and execute them with a lot of negotiating skill.
BIO will take place in Boston next year. Mark 4 to 7 June, 2018 on your calendar now and remember to register early. The joint stand sold out exceptionally quickly this year.
Contact
Jürgen Fuchs
Technology Expert Biotech & Pharma
Tel: +43 1 501 75 547
Mobile: +43 664 548 67 28
Email: fuchs@LISAvienna.at